Biotech

All Articles

BioAge eyes $180M from IPO, exclusive positioning for weight problems tests

.BioAge Labs is looking at around $180 thousand in preliminary profits coming from an IPO as well as...

Merck's LAG-3 combination neglects colon cancer phase 3 study

.An attempt through Merck &amp Co. to unlock the microsatellite secure (MSS) metastatic colon cancer...

Spanish VC shuts $200M lifestyle sciences fund

.Spain-based Asabys Partners has closed a fund of 180 thousand europeans ($ 200 thousand), funds tha...

BioAge produces $198M from IPO as excessive weight biotech participates in Nasdaq

.BioAge Labs is actually generating just about $200 million through its own Nasdaq IPO today, along ...

Acadia carries BMS veterinarian aboard as chief executive officer-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of substantial management hirings, firings an...

Cassava spends $40M over apparently deceptive Alzheimer's improve

.Cassava Sciences has actually agreed to pay for $40 thousand to resolve an inspection into cases it...

Merck bags options on Evaxion's AI-designed vaccination candidates

.Merck &amp Co. has grabbed possibilities on pair of Evaxion Biotech injection applicants, paying ou...

Enanta's RSV antiviral crushes virus-like load in difficulty research study

.Enanta Pharmaceuticals has linked its own respiratory syncytial infection (RSV) antiviral to consid...

Biogen containers SAGE-324 collaboration after vital shake neglect

.Biogen has actually provided the final rites to its own collaboration along with Sage Therapies on ...

AbbVie Parkinson's medicine coming from $8.7 B Cerevel buyout credit ratings

.On the exact same day that some Parkinson's health condition medications are actually being called ...